Xencor Inc (XNCR)

03:23 AM

Navigating the Valuation Gap in Xencor Shares - AD HOC NEWS

03:23 AM

Jan 15, 2026

Xencor (NASDAQ:XNCR) Shares Down 7.1%Here's Why - MarketBeat

Jan 15, 2026

Jan 14, 2026

Xencor (NASDAQ:XNCR) Shares Pass Below 50-Day Moving Average – Time to Sell? - Defense World

Jan 14, 2026

Jan 14, 2026

[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.

Jan 14, 2026

Jan 13, 2026

Merger Talk: What hedge fund activity signals for Xencor Inc stockJuly 2025 Action & Accurate Intraday Trade Tips - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Xencor (NASDAQ:XNCR) Shares Pass Below 50-Day Moving AverageTime to Sell? - MarketBeat

Jan 13, 2026

Jan 12, 2026

Performance Recap: Can Xencor Inc stock outperform in a bear marketMarket Risk Report & Safe Capital Growth Plans - baoquankhu1.vn

Jan 12, 2026

Jan 12, 2026

Weekly Earnings: Is Xencor Inc a top pick in the sector2025 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 12, 2026

Jan 12, 2026

ImmunityBio, Xencor Drugs Win E.U. Nods - Los Angeles Business Journal

Jan 12, 2026

Jan 10, 2026

How supply shortages influence Xencor Inc. (XE9) stockJuly 2025 Summary & High Accuracy Investment Entry Signals - Улправда

Jan 10, 2026

Jan 09, 2026

Xencor, Inc.Common Stock (NQ: XNCR - FinancialContent

Jan 09, 2026

Jan 09, 2026

Xencor outlines 2026 pipeline plans for cancer and autoimmune drugs By Investing.com - Investing.com Nigeria

Jan 09, 2026

Jan 09, 2026

IPO Launch: Will Xencor Inc stock reach Wall Street targetsWeekly Trade Summary & Daily Momentum Trading Reports - Bộ Nội Vụ

Jan 09, 2026

Jan 09, 2026

Xencor, Inc. (XNCR) Stock Analysis: Biotech Innovator With Over 100% Potential Upside - DirectorsTalk Interviews

Jan 09, 2026

Jan 09, 2026

Will Xencor Inc. stock benefit from upcoming earnings reports2025 Price Targets & Weekly Return Optimization Alerts - Улправда

Jan 09, 2026

Jan 08, 2026

How Xencor Inc. stock reacts to Fed rate cuts2025 Top Decliners & High Accuracy Investment Entry Signals - Улправда

Jan 08, 2026

Jan 08, 2026

Will Xencor Inc. stock reach Wall Street targetsQuarterly Investment Review & Community Consensus Trade Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Is Xencor Inc. stock in correction or buying zoneQuarterly Profit Summary & AI Based Trade Execution Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones - BioSpace

Jan 08, 2026

Jan 08, 2026

Xencor expects to have sufficient cash resources to fund research and development programs and operations through 2028 - marketscreener.com

Jan 08, 2026

Jan 08, 2026

Xencor Expects To Have Sufficient Cash Resources To Fund Research And Development Programs And Operations Through 2028 - TradingView — Track All Markets

Jan 08, 2026

Jan 08, 2026

Xencor outlines 2026 pipeline plans for cancer and autoimmune drugs - Investing.com

Jan 08, 2026

Jan 08, 2026

Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR) - The Globe and Mail

Jan 08, 2026

Jan 06, 2026

Star TribuneXencor, Inc.Common Stock (Nasdaq:XNCR) Stock Quote - FinancialContent

Jan 06, 2026

Jan 05, 2026

Xencor (NASDAQ:XNCR) Trading Down 7.1%Time to Sell? - MarketBeat

Jan 05, 2026

Jan 05, 2026

Incyte marks trial win for Xencor lymphoma drug (INCY:NASDAQ) - Seeking Alpha

Jan 05, 2026

Jan 03, 2026

Trading the Move, Not the Narrative: (XNCR) Edition - Stock Traders Daily

Jan 03, 2026

Jan 02, 2026

The Truth About Xencor Inc: Is This Quiet Biotech About To Explode? - AD HOC NEWS

Jan 02, 2026

Jan 01, 2026

Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 (NASDAQ:XNCR) - Seeking Alpha

Jan 01, 2026

Dec 31, 2025

Calculating The Fair Value Of Xencor, Inc. (NASDAQ:XNCR) - Yahoo Finance

Dec 31, 2025

Dec 28, 2025

Xencor issued US patent for Xtend FC domain - MSN

Dec 28, 2025

Dec 27, 2025

Xencor (NASDAQ:XNCR) VP John Desjarlais Sells 73,367 Shares - MarketBeat

Dec 27, 2025

Dec 26, 2025

Xencor (NASDAQ:XNCR) CEO Bassil Dahiyat Sells 114,377 Shares of Stock - MarketBeat

Dec 26, 2025

Dec 25, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 25, 2025

Dec 24, 2025

Xencor SVP Desjarlais sells $1.15 million in shares By Investing.com - Investing.com Nigeria

Dec 24, 2025

Dec 24, 2025

Responsive Playbooks and the XNCR Inflection - Stock Traders Daily

Dec 24, 2025

Dec 23, 2025

Xencor SVP Desjarlais sells $1.15 million in shares - Investing.com

Dec 23, 2025

Dec 23, 2025

With Xencor Stock Sliding, Have You Assessed The Risk? - Trefis

Dec 23, 2025

Dec 22, 2025

What drives Xencor Inc stock priceMarket Liquidity Analysis & Learn the Secrets of Pro Traders - earlytimes.in

Dec 22, 2025

Dec 20, 2025

Will Xencor Inc. (XE9) stock remain on Wall Street radar2025 Biggest Moves & Entry Point Strategy Guides - Улправда

Dec 20, 2025

Dec 20, 2025

Why Xencor Inc. stock attracts global investors2025 Institutional Moves & Low Risk High Reward Ideas - Улправда

Dec 20, 2025

Dec 19, 2025

VP Desjarlais Files To Sell 73,367 Of Xencor Inc [XNCR] - TradingView — Track All Markets

Dec 19, 2025

Dec 19, 2025

Can Xencor Inc. stock sustain revenue growth2025 Market Overview & Fast Gain Stock Trading Tips - Улправда

Dec 19, 2025

Dec 19, 2025

Growth Report: Is Xencor Inc. stock ready for breakoutPortfolio Return Report & Free Safe Entry Trade Signal Reports - Улправда

Dec 19, 2025

Dec 18, 2025

Can Xencor Inc. stock resist market sell offsJuly 2025 News Drivers & AI Powered Buy/Sell Recommendations - Улправда

Dec 18, 2025